Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0476089 (endometrial cancer)
 11,379 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

From October 1985 through September 1989, 46 patients with gynecologic malignancy had an incidental cholecystectomy at the time of surgery for their primary disease at the Albany Medical Center Hospital. The mean age was 59 (range 20-87 years). Indications for the gynecologic oncologic operation included endometrial carcinoma in 21 patients, suspected ovarian carcinoma in 17 patients and carcinoma of the cervix in 8 patients. Twenty-three patients (50%) had a preoperative diagnosis of cholelithiasis, and in the remaining 23 patients, the diagnosis of significant gallbladder disease was made intraoperatively. There was only 1 (2.2%) postoperative complication secondary to the cholecystectomy. Prophylactic cholecystectomy accompanying gynecologic cancer surgery can be performed safely and avoids the potential for postoperative cholecystitis and a second operative procedure.
 ...
PMID:Incidental cholecystectomy in the treatment of gynecologic malignancy. 1014 62

This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations for use of hormone replacement therapy for the primary prevention of chronic conditions in postmenopausal women and updates the 1996 USPSTF recommendations on this topic. The complete information on which this statement is based, including evidence tables and references, is available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and through the National Guideline Clearinghouse (http://www.guideline.gov) The USPSTF reviewed the evidence on the use of postmenopausal hormone replacement therapy and the following outcomes: cardiovascular disease, including CHD and stroke; osteoporosis and fractures; thromboembolism; dementia and cognitive function; breast, colon, ovarian, and endometrial cancer; and cholecystitis. The USPSTF also reviewed evidence of the effects of hormone replacement therapy on phytoestrogens and osteoporosis and cardiovascular disease. The use of hormone replacement therapy for relieving active symptoms of menopause, such as hot flashes, urogenital symptoms, and mood and sleep disturbances, among others, is outside the scope of these USPSTF recommendations, and literature on this topic was not reviewed. Sources for estimates of benefits and harms cited in this Recommendation statement are described in the summary of the evidence available from the Agency for Healthcare Research and Quality.
 ...
PMID:Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. 1243 33